Dexamethasone stimulates expression of insulin-like growth factor binding protein-1 in HEP G2 human hepatoma cells

D. Powell, Phillip Lee, L. A. DePaolis, S. L. Morris, A. Suwanichkul

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Insulin-like growth factor binding protein-1 (IGFBP-1) serum levels are increased by glucocorticoids and glucagon, and are decreased by insulin; these effects seem to reflect changes in hepatic IGFBP-1 expression. Human HEP G2 hepatoma cells respond to cAMP or insulin with stimulation or inhibition of IGFBP-1 expression, respectively; however, dexamethasone alone does not stimulate IGFBP-1 expression. Studies presented here show that in the presence of cAMP and theophylline, nontransfected HEP G2 cells respond to further addition of dexamethasone with a ~ 70% rise in IGFBP-1 mRNA levels, and HEP G2 cells transfected with IGFBP-1 promoter constructs respond to further addition of dexamethasone with a ~ 70% rise in IGFBP-1 protein levels and a ~ 9-fold rise in IGFBP-1 promoter activity. The stimulatory effect of dexamethasone and cAMP, confered to the IGFBP-1 promoter between 357 and 103 base pairs 5' to the mRNA cap site, is inhibited by insulin. Thus, the cis elements necessary to confer multihormonal regulation of IGFBP-1 expression appear to reside in a short stretch of DNA just upstream from the IGFBP-1 transcription start site.

Original languageEnglish (US)
Pages (from-to)11-13
Number of pages3
JournalGrowth Regulation
Volume3
Issue number1
StatePublished - 1993
Externally publishedYes

Fingerprint

Insulin-Like Growth Factor Binding Protein 1
Dexamethasone
Hepatocellular Carcinoma
Insulin
Messenger RNA
Transcription Initiation Site
Theophylline
Glucagon
Base Pairing
Glucocorticoids

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Dexamethasone stimulates expression of insulin-like growth factor binding protein-1 in HEP G2 human hepatoma cells. / Powell, D.; Lee, Phillip; DePaolis, L. A.; Morris, S. L.; Suwanichkul, A.

In: Growth Regulation, Vol. 3, No. 1, 1993, p. 11-13.

Research output: Contribution to journalArticle

Powell, D. ; Lee, Phillip ; DePaolis, L. A. ; Morris, S. L. ; Suwanichkul, A. / Dexamethasone stimulates expression of insulin-like growth factor binding protein-1 in HEP G2 human hepatoma cells. In: Growth Regulation. 1993 ; Vol. 3, No. 1. pp. 11-13.
@article{f128395073fb4674891820ead13a702a,
title = "Dexamethasone stimulates expression of insulin-like growth factor binding protein-1 in HEP G2 human hepatoma cells",
abstract = "Insulin-like growth factor binding protein-1 (IGFBP-1) serum levels are increased by glucocorticoids and glucagon, and are decreased by insulin; these effects seem to reflect changes in hepatic IGFBP-1 expression. Human HEP G2 hepatoma cells respond to cAMP or insulin with stimulation or inhibition of IGFBP-1 expression, respectively; however, dexamethasone alone does not stimulate IGFBP-1 expression. Studies presented here show that in the presence of cAMP and theophylline, nontransfected HEP G2 cells respond to further addition of dexamethasone with a ~ 70{\%} rise in IGFBP-1 mRNA levels, and HEP G2 cells transfected with IGFBP-1 promoter constructs respond to further addition of dexamethasone with a ~ 70{\%} rise in IGFBP-1 protein levels and a ~ 9-fold rise in IGFBP-1 promoter activity. The stimulatory effect of dexamethasone and cAMP, confered to the IGFBP-1 promoter between 357 and 103 base pairs 5' to the mRNA cap site, is inhibited by insulin. Thus, the cis elements necessary to confer multihormonal regulation of IGFBP-1 expression appear to reside in a short stretch of DNA just upstream from the IGFBP-1 transcription start site.",
author = "D. Powell and Phillip Lee and DePaolis, {L. A.} and Morris, {S. L.} and A. Suwanichkul",
year = "1993",
language = "English (US)",
volume = "3",
pages = "11--13",
journal = "Growth Regulation",
issn = "0956-523X",
publisher = "Churchill Livingstone",
number = "1",

}

TY - JOUR

T1 - Dexamethasone stimulates expression of insulin-like growth factor binding protein-1 in HEP G2 human hepatoma cells

AU - Powell, D.

AU - Lee, Phillip

AU - DePaolis, L. A.

AU - Morris, S. L.

AU - Suwanichkul, A.

PY - 1993

Y1 - 1993

N2 - Insulin-like growth factor binding protein-1 (IGFBP-1) serum levels are increased by glucocorticoids and glucagon, and are decreased by insulin; these effects seem to reflect changes in hepatic IGFBP-1 expression. Human HEP G2 hepatoma cells respond to cAMP or insulin with stimulation or inhibition of IGFBP-1 expression, respectively; however, dexamethasone alone does not stimulate IGFBP-1 expression. Studies presented here show that in the presence of cAMP and theophylline, nontransfected HEP G2 cells respond to further addition of dexamethasone with a ~ 70% rise in IGFBP-1 mRNA levels, and HEP G2 cells transfected with IGFBP-1 promoter constructs respond to further addition of dexamethasone with a ~ 70% rise in IGFBP-1 protein levels and a ~ 9-fold rise in IGFBP-1 promoter activity. The stimulatory effect of dexamethasone and cAMP, confered to the IGFBP-1 promoter between 357 and 103 base pairs 5' to the mRNA cap site, is inhibited by insulin. Thus, the cis elements necessary to confer multihormonal regulation of IGFBP-1 expression appear to reside in a short stretch of DNA just upstream from the IGFBP-1 transcription start site.

AB - Insulin-like growth factor binding protein-1 (IGFBP-1) serum levels are increased by glucocorticoids and glucagon, and are decreased by insulin; these effects seem to reflect changes in hepatic IGFBP-1 expression. Human HEP G2 hepatoma cells respond to cAMP or insulin with stimulation or inhibition of IGFBP-1 expression, respectively; however, dexamethasone alone does not stimulate IGFBP-1 expression. Studies presented here show that in the presence of cAMP and theophylline, nontransfected HEP G2 cells respond to further addition of dexamethasone with a ~ 70% rise in IGFBP-1 mRNA levels, and HEP G2 cells transfected with IGFBP-1 promoter constructs respond to further addition of dexamethasone with a ~ 70% rise in IGFBP-1 protein levels and a ~ 9-fold rise in IGFBP-1 promoter activity. The stimulatory effect of dexamethasone and cAMP, confered to the IGFBP-1 promoter between 357 and 103 base pairs 5' to the mRNA cap site, is inhibited by insulin. Thus, the cis elements necessary to confer multihormonal regulation of IGFBP-1 expression appear to reside in a short stretch of DNA just upstream from the IGFBP-1 transcription start site.

UR - http://www.scopus.com/inward/record.url?scp=0027246488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027246488&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 11

EP - 13

JO - Growth Regulation

JF - Growth Regulation

SN - 0956-523X

IS - 1

ER -